Načítá se...
Modulation of cGMP in Heart Failure: A New Therapeutic Paradigm
Heart failure (HF) is a common disease that continues to be associated with high morbidity and mortality warranting novel therapeutic strategies. Cyclic guanosine monophosphate (cGMP) is the second messenger of several important signaling pathways based on distinct guanylate cyclases (GCs) in the ca...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3835600/ https://ncbi.nlm.nih.gov/pubmed/19089342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-3-540-68964-5_21 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|